Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
003520.KS Stock Summary
Top 10 Correlated ETFs
003520.KS
In the News
003520.KS Financial details
Company Rating
Buy
Market Cap
550.5B
Income
-6.67B
Revenue
212.74B
Book val./share
564.68
Cash/share
-
Dividend
-
Dividend %
-
Employees
574
Optionable
No
Shortable
Yes
Earnings
08 May 2023
P/E
-78.85
Forward P/E
-
PEG
-0.16
P/S
2.47
P/B
5.27
P/C
-
P/FCF
-25.09
Quick Ratio
-
Current Ratio
1.9
Debt / Equity
1.04
LT Debt / Equity
-
-
-
EPS (TTM)
-37.2
EPS next Y
-
EPS next Q
-
EPS this Y
8599.07%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
0.11%
Revenue Q/Q
4.17%
EPS Q/Q
48.26%
-
-
-
-
SMA20
-15.48%
SMA50
-8.72%
SMA100
12.23%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-7%
ROC
-0.05%
Gross Margin
30%
Oper. Margin
-4%
Profit Margin
-3%
Payout
-
Shs Outstand
182.89M
Shs Float
84.74M
-
-
-
-
Target Price
-
52W Range
2390.0-5670.0
52W High
-47.53%
52W Low
+24.48%
RSI
39
Rel Volume
0.47
Avg Volume
714.9K
Volume
334.01K
Perf Week
-1.16%
Perf Month
-19.27%
Perf Quarter
21.43%
Perf Half Y
8.78%
-
-
-
-
Beta
1.15345
-
-
Volatility
64.53%, 258.16%
Prev Close
-0.17%
Price
2975
Change
-1.33%
003520.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 1.07K | 1.02K | 1.21K | 1.14K | 1.07K | |
Net income per share | 10.22 | -33.36 | 27.5 | -0.73 | -63.33 | |
Operating cash flow per share | 17.25 | 6.97 | 50.75 | 79.27 | 45.75 | |
Free cash flow per share | -42.9 | -18.77 | -5.88 | 44.8 | -16.14 | |
Cash per share | 66.7 | 10.03 | 3.56 | 2.34 | 2.54 | |
Book value per share | 654.98 | 610.23 | 632.89 | 625.68 | 573.48 | |
Tangible book value per share | 612.33 | 597.44 | 620.79 | 617.12 | 565.6 | |
Share holders equity per share | 654.98 | 610.23 | 632.89 | 625.68 | 573.48 | |
Interest debt per share | 101.94 | 68.7 | 79.99 | 41.21 | 72.55 | |
Market cap | 1644.08B | 1086.38B | 1212.58B | 1470.46B | 967.5B | |
Enterprise value | 1658.06B | 1096.84B | 1226.56B | 1477.31B | 980.1B | |
P/E ratio | 880.26 | -178.07 | 241.07 | -11.05K | -83.53 | |
Price to sales ratio | 8.43 | 5.83 | 5.5 | 7.05 | 4.93 | |
POCF ratio | 521.64 | 852.61 | 130.63 | 101.43 | 115.62 | |
PFCF ratio | -209.77 | -316.4 | -1.13K | 179.48 | -327.74 | |
P/B Ratio | 13.74 | 9.73 | 10.48 | 12.85 | 9.22 | |
PTB ratio | 13.74 | 9.73 | 10.48 | 12.85 | 9.22 | |
EV to sales | 8.5 | 5.88 | 5.56 | 7.09 | 5 | |
Enterprise value over EBITDA | 168.28 | 4.17K | 71.95 | 178.54 | -149.48 | |
EV to operating cash flow | 526.07 | 860.82 | 132.14 | 101.9 | 117.13 | |
EV to free cash flow | -211.56 | -319.44 | -1.14K | 180.32 | -332.01 | |
Earnings yield | 0 | -0.01 | 0 | 0 | -0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0.01 | 0 | |
Debt to equity | 0.7 | 0.76 | 0.73 | 0.64 | 0.85 | |
Debt to assets | 0.41 | 0.43 | 0.42 | 0.39 | 0.46 | |
Net debt to EBITDA | 1.42 | 39.73 | 0.82 | 0.83 | -1.92 | |
Current ratio | 3.04 | 2.88 | 2.8 | 3.27 | 1.86 | |
Interest coverage | 6.54 | -8.02 | 0 | 1.51 | -66.41 | |
Income quality | 1.69 | -0.21 | 1.85 | -108.91 | -0.72 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
Research and developement to revenue | 0.07 | 0.06 | 0.06 | 0.07 | 0.07 | |
Intangibles to total assets | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -3.49 | -3.69 | -1.12 | -0.43 | -1.35 | |
Capex to revenue | -0.06 | -0.03 | -0.05 | -0.03 | -0.06 | |
Capex to depreciation | -1.66 | -0.71 | -1.35 | -0.81 | -1.53 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 388.17 | 676.76 | 625.8 | 101.23 | 903.97 | |
ROIC | 0.01 | -0.01 | 0.03 | 0 | -0.06 | |
Return on tangible assets | 0.01 | -0.03 | 0.03 | 0 | -0.06 | |
Graham Net | -282.84 | -321.27 | -306.54 | -259.84 | -376.83 | |
Working capital | 76.55B | 71.58B | 71.54B | 68.53B | 41.36B | |
Tangible asset value | 111.86B | 109.27B | 113.54B | 112.87B | 103.44B | |
Net current asset value | 29.82B | 25.18B | 26.64B | 25.01B | 478.24M | |
Invested capital | 0.15 | 0.11 | 0.13 | 0.06 | 0.12 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 14.86B | 16.02B | 16.47B | 11.86B | 12.83B | |
Average inventory | 42.4B | 44.26B | 51.9B | 53.7B | 45.54B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 36.84 | 56.37 | 35.38 | 27.26 | 41.17 | |
Days of inventory on hand | 117.71 | 139.71 | 145.12 | 139.07 | 104.78 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 9.91 | 6.47 | 10.32 | 13.39 | 8.87 | |
Inventory turnover | 3.1 | 2.61 | 2.52 | 2.62 | 3.48 | |
ROE | 0.02 | -0.05 | 0.04 | 0 | -0.11 | |
Capex per share | -60.16 | -25.74 | -56.63 | -34.47 | -61.89 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 270.42 | 294.83 | 288.07 | 294.83 | 307.11 | |
Net income per share | -20.83 | -9.34 | -8 | -8 | -11.86 | |
Operating cash flow per share | 46.67 | -10.71 | -50.32 | 37.3 | -7.01 | |
Free cash flow per share | 29.4 | -37.05 | -89.47 | 25.98 | -18.37 | |
Cash per share | 0 | 2.54 | 1.91 | 4.67 | 0 | |
Book value per share | 571.71 | 573.48 | 569.3 | 576.59 | 564.68 | |
Tangible book value per share | 571.71 | 565.6 | 563.08 | 563.09 | 564.68 | |
Share holders equity per share | 571.71 | 573.48 | 569.3 | 576.59 | 564.68 | |
Interest debt per share | 0 | 71.71 | 162.16 | 145.24 | -0.5 | |
Market cap | 919.95B | 967.5B | 944.64B | 641.25B | 465.24B | |
Enterprise value | 919.95B | 980.1B | 973.62B | 665.92B | 465.24B | |
P/E ratio | -60.36 | -141.62 | -162.5 | -113.28 | -55.44 | |
Price to sales ratio | 18.6 | 17.94 | 18.05 | 12.3 | 8.56 | |
POCF ratio | 107.79 | -493.98 | -103.35 | 97.19 | -375.36 | |
PFCF ratio | 171.09 | -142.8 | -58.12 | 139.52 | -143.18 | |
P/B Ratio | 8.8 | 9.22 | 9.13 | 6.29 | 4.66 | |
PTB ratio | 8.8 | 9.22 | 9.13 | 6.29 | 4.66 | |
EV to sales | 18.6 | 18.18 | 18.6 | 12.77 | 8.56 | |
Enterprise value over EBITDA | -389.74 | -864.7 | 2.25K | 1.75K | -191.48 | |
EV to operating cash flow | 107.79 | -500.41 | -106.52 | 100.92 | -375.36 | |
EV to free cash flow | 171.09 | -144.65 | -59.9 | 144.88 | -143.18 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0.01 | -0.01 | -0.02 | 0.01 | -0.01 | |
Debt to equity | 0.77 | 0.85 | 0.96 | 1 | 1.04 | |
Debt to assets | 0.43 | 0.46 | 0.49 | 0.5 | 0.51 | |
Net debt to EBITDA | 0 | -11.11 | 66.95 | 64.7 | 0 | |
Current ratio | 2.7 | 1.86 | 1.68 | 2.01 | 1.9 | |
Interest coverage | 0 | -50.46 | -5.97 | -7.45 | 26.41 | |
Income quality | -2.24 | 1.15 | 6.29 | -4.66 | 0.59 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.36 | 0.02 | 0.02 | 0.01 | 0.33 | |
Research and developement to revenue | 0 | 0.06 | 0.06 | 0.06 | 0 | |
Intangibles to total assets | 0 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | -0.37 | 2.46 | 0.78 | -0.3 | 1.62 | |
Capex to revenue | -0.06 | -0.09 | -0.14 | -0.04 | -0.04 | |
Capex to depreciation | -1.75 | -2.68 | -3.94 | -1.07 | -1.01 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 517.67 | 347.13 | 320.11 | 322.16 | 388.19 | |
ROIC | 0.07 | -0.01 | 0 | -0.01 | -0.01 | |
Return on tangible assets | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | |
Graham Net | -440.03 | -376.83 | -430.47 | -431.63 | -587.81 | |
Working capital | 57.11B | 41.36B | 40.4B | 51.39B | 48B | |
Tangible asset value | 104.56B | 103.44B | 102.29B | 99.61B | 99.89B | |
Net current asset value | 10.32B | 478.24M | -160.55M | 189.26M | -2.72B | |
Invested capital | 0 | 0.12 | 0.28 | 0.25 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 6.93B | 7.79B | 15.55B | 18.81B | 11.04B | |
Average inventory | 24.8B | 19.83B | 41.03B | 45.98B | 24.78B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 37 | 38.51 | 54.76 | 0 | |
Days of inventory on hand | 0 | 94.18 | 105.21 | 122.87 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 2.43 | 2.34 | 1.64 | 0 | |
Inventory turnover | 0 | 0.96 | 0.86 | 0.73 | 0 | |
ROE | -0.04 | -0.02 | -0.01 | -0.01 | -0.02 | |
Capex per share | -17.27 | -26.34 | -39.16 | -11.32 | -11.36 |
003520.KS Frequently Asked Questions
What is Yungjin Pharm. Co., Ltd. stock symbol ?
Yungjin Pharm. Co., Ltd. is a KR stock and trading under the symbol 003520.KS
What is Yungjin Pharm. Co., Ltd. stock quote today ?
Yungjin Pharm. Co., Ltd. stock price is $2975 today.
Is Yungjin Pharm. Co., Ltd. stock public?
Yes, Yungjin Pharm. Co., Ltd. is a publicly traded company.